8-Hydroxyquinolines are bactericidal against Mycobacterium tuberculosis
- PMID: 30893501
- PMCID: PMC6767403
- DOI: 10.1002/ddr.21531
8-Hydroxyquinolines are bactericidal against Mycobacterium tuberculosis
Abstract
There is an urgent need for new treatments effective against Mycobacterium tuberculosis, the causative agent of tuberculosis. The 8-hydroxyquinoline series is a privileged scaffold with anticancer, antifungal, and antibacterial activities. We conducted a structure-activity relationship study of the series regarding its antitubercular activity using 26 analogs. The 8-hydroxyquinolines showed good activity against M. tuberculosis, with minimum inhibitory concentrations (MIC90) of <5 μM for some analogs. Small substitutions at C5 resulted in the most potent activity. Substitutions at C2 generally decreased potency, although a sub-family of 2-styryl-substituted analogs retained activity. Representative compounds demonstrated bactericidal activity against replicating M. tuberculosis with >4 log kill at 10× MIC over 14 days. The majority of the compounds demonstrated cytotoxicity (IC50 of <100 μM). Further development of this series as antitubercular agents should address the cytotoxicity liability. However, the 8-hydroxyquinoline series represents a useful tool for chemical genomics to identify novel targets in M. tuberculosis.
Keywords: Mycobacterium tuberculosis; tuberculosis; antibacterial; hydroxyquinoline; structure-activity relationship.
© 2019 The Authors. Drug Development Research published by Wiley Periodicals, Inc.
Conflict of interest statement
The authors declare they have no conflict of interest.
Figures
References
-
- Abouelhassan, Y. , Garrison, A. T. , Burch, G. M. , Wong, W. , Norwood, V. M. , & Huigens, R. W. (2014). Discovery of quinoline small molecules with potent dispersal activity against methicillin‐resistant Staphylococcus aureus and Staphylococcus epidermidis biofilms using a scaffold hopping strategy. Bioorganic & Medicinal Chemistry Letters, 24(21), 5076–5080. 10.1016/j.bmcl.2014.09.009 - DOI - PubMed
-
- Ananthan, S. , Faaleolea, E. R. , Goldman, R. C. , Hobrath, J. V. , Kwong, C. D. , Laughon, B. E. , … White, E. L. (2009). High‐throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv. Tuberculosis (Edinburgh, Scotland), 89(5), 334–353. 10.1016/j.tube.2009.05.008 - DOI - PMC - PubMed
-
- Barilli, A. , Atzeri, C. , Bassanetti, I. , Ingoglia, F. , Dall'Asta, V. , Bussolati, O. , … Marchiò, L. (2014). Oxidative stress induced by copper and iron complexes with 8‐hydroxyquinoline derivatives causes paraptotic death of HeLa cancer cells. Molecular Pharmaceutics, 11(4), 1151–1163. 10.1021/mp400592n - DOI - PubMed
-
- Basak, A. , Abouelhassan, Y. , Norwood, V. M. , Bai, F. , Nguyen, M. T. , Jin, S. , & Huigens, R. W. (2016). Synthetically tuning the 2‐position of halogenated quinolines: Optimizing antibacterial and biofilm eradication activities via alkylation and reductive amination pathways. Chemistry, 22(27), 9181–9189. 10.1002/chem.201600926 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
